Trade Summary

6 days ago, Bergmann Anthony, serving as CHIEF FINANCIAL OFFICER at CAPRICOR THERAPEUTICS, INC. (CAPR), sold 24,100 shares at $30.38 per share, for a total transaction value of $732,158.00. Following this transaction, Bergmann Anthony now holds 11,223 shares of CAPR.

This sale represents a 68.23% decrease in Bergmann Anthony's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 (accepted Jun 29, 9:30 PM ET), 5 days after the trade was made.

CAPRICOR THERAPEUTICS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.